baber/WOPTO huggingface dataset:
Patent AU-2015223484-A1 (AU)
Title: Optical communication terminal
Inventor: ERKMEN BARIS IBRAHIM
IPC: H04B10/25
Filed: 2015-01-22
Abstract: An optical communication terminal is configured to operate in two different complementary modes of full duplex communication. In one mode, the terminal transmits light having a first wavelength and receives light having a second wavelength along a common free space optical path. In the other mode, the terminal transmits light having the second wavelength and receives light having the first wavelength. The terminal includes a steering mirror that directs light to and from a dichroic element that creates different optical paths depending on wavelength, and also includes spatially separated emitters and detectors for the two wavelengths. A first complementary emitter/detector pair is used in one mode, and a second pair is used for the other mode. The optical components are arranged such that adjusting an orientation of the steering mirror aligns the terminal to communication over a given free space optical link using either the first or second complementary pair.
Patent AU-2015236282-A1 (AU)
Title: Magnetic connection and alignment of connectible devices
Inventor: GOLKO ALBERT J
IPC: H02J7/02
Filed: 2015-03-24
Abstract: A first and second electronic device each including a connection surface and a magnetic element. The first and second devices may be in contact along the respective connection surfaces. The magnetic elements may be configured to align the first and second devices by moving either or both of the first and second devices relative to each other to achieve an aligned position. The magnetic element may also be operative to resist disconnection of first and second electronic devices when in the aligned position.
Patent AU-2015236327-A1 (AU)
Title: Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders
Inventor: SURESH LAKSHMANAN
IPC: C07K14/475
Filed: 2015-03-24
Abstract: Provided are compositions that contain mammalian cells for use in detecting antibodies. The mammalian cells are modified such that they do not contain LEDGF protein. The mammalian cells are immobilized on a solid substrate. The compositions can also contain mammalian cells that contain the LEDGF protein. Methods for using the cell compositions in diagnostic approaches are included, as are kits for performing diagnostic tests.
Patent AU-2015249166-A1 (AU)
Title: Registration maps using intra-cardiac signals
Inventor: URMAN ROY
IPC: G16B45/00
Filed: 2015-10-30
Abstract: Cardiac catheterization is facilitated by generating first and second electroanatomic maps of a heart of a subject and designating common spatial locations that correspond to first electrical events on the first electroanatomic map and second electrical events on the second electroanatomic map. The common spatial locations of the first electroanatomic map and the second electroanatomic map are aligned to establish an aligned map, and using the location data on the aligned map to guide a probe to a point of interest. -------
Patent AU-2015258237-A1 (AU)
Title: Power Monitoring System
Inventor: GELONESE DOMENICO
IPC: G06F1/26
Filed: 2015-11-19
Abstract: A set top box is disclosed that includes a means to detect that a television connected to said set-top box is not in use, and a means to place said television into a lower energy usage state thus reducing energy consumption
Patent AU-2015261702-A1 (AU)
Title: Recovery or removal of nutrients from run-off or agricultural, industrial, commercial or domestic waste flow
Inventor: LONG TOM
IPC: C02F1/28
Filed: 2015-11-29
Abstract: A treatment medium has a particulate natural substrate saturated, suffused and/or coated with hydrous iron oxide. The particulate substrate can be wood based, such as wood chips, bark, sawdust, wood waste or other plant material (such as straw, lucerne, hay, coconut husk or other bulk particulate plant material). The hydrous iron oxide is provided in aqueous suspension form. The substrate may be tumbled in aqueous hydrous iron suspension to achieve saturation/coating. The resulting hydrous iron oxide bearing medium is either placed loose directly into the target treatment site or contained in bags 18 before placing into the target site. ms-,
Patent AU-2015275151-A1 (AU)
Title: Flexible conductor for use within a contact lens
Inventor: LINHARDT JEFFREY G
IPC: H02N2/02
Filed: 2015-05-15
Abstract: An eye-mountable device includes a flexible lens enclosure, anterior and posterior flexible conductive electrodes, and an accommodation actuator element. The flexible lens enclosure includes anterior and posterior layers that are sealed together. The anterior flexible conductive electrode is disposed within the flexible enclosure and across a center region of the flexible lens enclosure on a concave side of the anterior layer. The posterior flexible conductive electrode is disposed within the flexible enclosure and across the center region on a convex side of the posterior layer. The accommodation actuator element is disposed between the first and second flexible conductive electrodes. The anterior and posterior flexible conductive electrodes are transparent and electrically manipulate the accommodation actuator element.
Patent AU-2015282588-A1 (AU)
Title: Flow cytometry assembly and system, analysing device comprising such a cytometry assembly and assembly comprising such a cytometry system
Inventor: ROUSSEAU ALAIN
IPC: G01N15/10
Filed: 2015-06-23
Abstract: This flow cytometry system comprises: a measuring chamber (11); an injecting device (12) arranged to inject a flow of biological particles to be analysed into the measuring chamber (11); an evacuating device (13) arranged to evacuate to the exterior of the cytometry system the flux of biological particles injected into the measuring chamber (11); a measuring assembly arranged to measure at least one optical property of the biological particles to be analysed, the measuring assembly including an emitting device (42) arranged to emit a light beam in the direction of the measuring chamber (11) and able to cross the flow of biological particles; and at least one collecting device (43a) arranged to collect light rays issued from the measuring chamber (11). The flow cytometry system furthermore comprises a supporting member (6) on which the injecting device (12), the evacuating device (13), the emitting device (42) and the at least one collecting device (43a) are arranged.
Patent AU-2015296866-A1 (AU)
Title: Separating device for removing solid particles from liquid and gas flows for high differential pressures
Inventor: LANGE DIETRICH
IPC: E21B43/08
Filed: 2015-07-27
Abstract: The subject matter of the invention is a separating device for removing solid particles from liquids and/or gases in extraction wells, comprising a) an annular stack (7) of at least three brittle-hard annular discs (8), the upper side (9) of the annular discs (8) having at least three spacers (10), which are distributed uniformly over the circular circumference of the discs and the contact area (11) of which is planar, so that the spacers (10) have planiform contact with the underside of an adjacent annular disc (8), and the annular discs (8) being stacked and fixed in such a way that between the individual discs (8) there is in each case a separating gap (14) for the removal of solid particles, and the axial projection of the annular discs (8) at the inner and the outer circumference being circular, and the brittle-hard material of the annular discs (8) being chosen from oxidic and non-oxidic ceramic materials, mixed ceramics of these materials, ceramic materials with the addition of secondary phases, mixed materials with fractions of ceramic or metallic hard materials and with a metallic binding phase, powder-metallurgical materials with hard material phases formed in situ and long- and/or short-fibre-reinforced ceramic materials, b) a perforated pipe (1), which is located inside the annular stack (7) and on which the brittle-hard annular discs (8) are stacked, c) at least three bands (15), which are provided axially parallel and uniformly spaced apart on the lateral surface (21) of the perforated pipe (1) located inside the annular stack (7) and onto which the annular discs (8) have been pushed, whereby the annular discs (8) are centred on the perforated pipe (1), and d) an end cap (5) at the upper end and an end cap (6) at the lower end of the annular stack (7), the end caps (5, 6) being firmly connected to the perforated pipe (1). The subject matter of the invention is likewise the use of a separating device according to the invention for removing solid particles from liquids and/or gases in a process for extracting liquids and/or gases from extraction wells
Patent AU-2015321700-A1 (AU)
Title: Component-specific application presentation histories
Inventor: MORAN KERI KRUSE
IPC: G06F9/44
Filed: 2015-09-18
Abstract: In many computing scenarios, a computing environment of a device may present applications through various presentation components, such as displays, speakers, and headphones. However, navigating among the applications currently presented within the computing environment may be difficult for the user; e.g., for a device presenting many applications on many displays that share an application stack, the application that the user wishes to select may be buried deep within the shared application stack. In accordance with the techniques presented herein, the device may generate an application presentation history for each presentation component, indicating applications that have previously been presented through the presentation component. A request to transition a selected presentation component away from a current application presentation may be fulfilled by identifying a second application having an application presentation in the application presentation history of the selected presentation component, and transitioning the selected presentation component to the second application.
Patent AU-2015324294-A1 (AU)
Title: Medical device cap for drug transfer assembly
Inventor: SATHE TUSHAR R
IPC: A61M39/20
Filed: 2015-09-24
Abstract: A medical device cap that protectively surrounds a medical device component for disinfection purposes and includes an identification element that can record and transmit pertinent information of the medical device cap and the medical device component is disclosed. The medical device cap enables documentation of instances when the cap is used and promotes stronger compliance with the use of medical device caps for applications involving disinfection of a medical device component such as an IV access port or a luer tip. Use of the medical device cap results in better compliance and monitoring of the use of such caps and leads to reduced incidence of CRBSI infections related to medical device component contamination. In one embodiment, the medical device cap enables automated real-time electronic documentation of when the cap is applied, while also documenting duration of application and tracking of device for inventory management.
Patent AU-2015342882-A1 (AU)
Title: Improved IL-6 antibodies
Inventor: SCHMIDT MICHAEL MARCH
IPC: C07K16/24
Filed: 2015-11-06
Abstract: Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed.
Patent AU-2015343699-A1 (AU)
Title: Motion driven cooling system
Inventor: FRENCH JOSEPH A
IPC: B60H1/32
Filed: 2015-08-11
Abstract: A motion driven cooling system configured to operate with one or more transportation devices. The motion driven cooling system includes a moving object in communication with a transportation device. The moving object transfers power from the movement of the transportation device and operates a water pump system and a fan system. The cooling system includes a water housing configured to retain water. The water pump communicates with the moving object and is configured to move water from the water housing to a second location where the water passes through one or more elements and returns to the water housing. The fan communicates with the moving object and is configured to move air across the water at the second location so as to lower the temperature of the air. An outlet port directs the flow of air as desired.
Patent AU-2015411533-A1 (AU)
Title: High availability compressor for a gas compression system
Inventor: CORTINOVIS ANDREA
IPC: F04D27/02
Filed: 2015-10-07
Abstract: A method is disclosed for controlling at least one compressor (13) in a gas compression system (60), the compressor being driven by an electric motor (3) powered by a drive (2). The method further comprises obtaining measurements of one or more process variables (21) for the compressor and/or compression system from sensors mounted in the compressor or the gas compression system and obtaining a value of at least one electrical parameter (31) from the drive (2) and/or the electric motor (3). Further an estimation (35) of at least one process variable is calculated and compared with a measurement of the process variable (
Patent AU-2016200462-A1 (AU)
Title: Methods, reagents and kits for flow cytometric immunophenotyping
Inventor: VAN DONGEN JACOBUS JOHANNES MARIA
IPC: G01N33/58
Filed: 2016-01-27
Abstract: Title: Methods, reagents and kits for flow cytometric immunophenotyping. Abstract The invention relates to the field of flow cytometry and more particularly to a panel of antibody reagents conjugated to fluorescent compounds. Provided are reagent compositions, comprising at least eight distinct fluorochrome-conjugated antibodies comprising a set of at least three identification antibodies for the identification of a leukocyte population of interest and at least four characterization antibodies for further characterization and/or classification of said leukocyte population. Also provided are kits and methods related to the reagent compositions.
Patent AU-2016200485-A1 (AU)
Title: Compounds and methods for kinase modulation, and indications therefor
Inventor: IBRAHIM PRABHA N
IPC: A61K31/519
Filed: 2016-01-28
Abstract: COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Abstract Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one Raf protein kinase. In certain aspects and embodiments, the described compounds are active in inhibiting proliferation of a Ras mutant cell line. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of B-Raf V600E mutant protein kinase, including melanoma, glioma, glioblastoma multiforme, pilocytic astrocytoma, colorectal cancer, thyroid cancer, lung cancer, ovarian cancer, prostate cancer, liver cancer, gallbladder cancer, gastrointestinal stromal tumors, biliary tract cancer, and cholangiocarcinoma. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of c-Raf-1 protein kinase, including acute pain, chronic pain or polycystic kidney disease. (7390015 1):KZA
Patent AU-2016201017-A1 (AU)
Title: Percutaneous, ultrasound-guided introduction of medical devices
Inventor: FEARNOT NEAL E
IPC: A61M25/095
Filed: 2016-02-18
Abstract: Described are methods and systems and system components useful for percutaneously delivering or retrieving vascular implant devices, such as filters, utilizing intravenous ultrasound (IVUS) imaging alone or in combination with external (e.g. transabdominal) ultrasound or other imaging technology. Implants deliverable by such systems, such as vena cava or other vascular filters, can have two or more echogenic markers spaced at such a distance that they are separately discernible by IVUS and/or external ultrasound imaging.
Patent AU-2016201039-A1 (AU)
Title: An external charger for an implantable medical device system having a coil for communication and charging
Inventor: AGHASSIAN DANIEL
IPC: A61N1/372
Filed: 2016-02-19
Abstract: A method for operating an implantable medical device system, comprising: compiling, at an external controller, information to be sent to an implantable medical device; sending a first communication using a protocol from the external controller to an external charger, the first communication instructing the external charger to turn off a charging field; and thereafter sending the compiled information from the external controller to the implantable medical device using the protocol, and a method for operating an implantable medical device system, comprising: sending a first communication, using a protocol, from an external controller to an external charger to cease an operation between the external charger and an implantable medical device; transmitting data between the external controller and the implantable medical device using the protocol; and sending a second communication, using the protocol, from the external controller to the external charger to allow resumption of the operation between the external charger and the implantable medical device.
Patent AU-2016214792-A1 (AU)
Title: Ostomy device
Inventor: STROEBECH ESBEN
IPC: C09J7/00
Filed: 2016-02-02
Abstract: Disclosed is an ostomy device with an adhesive wafer for attachment to a skin surface (S) of a user and a collecting bag (8) or collecting output from a stoma. The collecting bag is connected to the adhesive wafer, and the adhesive wafer has a through-going hole (6) for accommodating the stoma (7) of the user. The adhesive wafer includes a backing layer (3), a first switchable adhesive composition (2), a second absorbent adhesive composition (1), and a release liner, and the second adhesive layer has a central portion with a first thickness and an edge portion with a second thickness, the first thickness being larger than the second thickness.
Patent AU-2016215637-A1 (AU)
Title: Compositions and methods for scale inhibition
Inventor: Charlesworth Mark
IPC: C02F1/68
Filed: 2016-01-29
Abstract: A method for inhibiting the formation, deposition and adherence of scale to metallic and other surfaces in the equipment, vessels and/or piping of facilities for the handling of oil and gas produced fluid is disclosed. An effective scale inhibiting amount of alginate is added to a produced fluid containing a scale-forming divalent cation. The alginate effectively cross-links with a scale-forming divalent cation, e.g., calcium, forming an alginate gel for subsequent separation and removal from the produced fluid.
Patent AU-2016219736-A1 (AU)
Title: Surgical instrument with stamped double-flag jaws and actuation mechanism
Inventor: ALLEN IV JAMES D
IPC: A61B17/28
Filed: 2016-08-29
Abstract: SURGICAL INSTRUMENT WITH STAMPED DOUBLE-FLAG JAWS AND ACTUATION MECHANISM A surgical instrument, comprising: a housing (12); an elongated shaft (16) coupled to the housing and defining a longitudinal axis; a pair of opposing jaw members (30, 32) disposed at a distal portion of the elongated shaft (16); and a drive rod (80) having a generally u-shaped profile and configured to move longitudinally within the elongated shaft (16) to move at least one of the jaw members relative to the other jaw member.
Patent AU-2016220032-A1 (AU)
Title: Stabilizing sorbic acid in beverage syrup
Inventor: MUTILANGI WILLIAM
IPC: A23L2/52
Filed: 2016-02-18
Abstract: A method for preparing a sorbate powder comprising dissolving sorbate salt in water, adding a stabilizing carrier to the sorbate solution, and spray drying the sorbate solution to form the sorbate powder. The sorbate powder is stable in beverage syrup.
Patent AU-2016229101-A1 (AU)
Title: Glucosylceramide synthase inhibitors for the treatment of diseases
Inventor: WANG BING
IPC: A61K31/535
Filed: 2016-03-10
Abstract: Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).
Patent AU-2016250354-A1 (AU)
Title: Activin-ActRII antagonists and uses for increasing red blood cell levels
Inventor: SHERMAN MATTHEW L
IPC: C12N15/62
Filed: 2016-10-25
Abstract: In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and prirnates, and particularly in humans
Patent AU-2016255255-A1 (AU)
Title: Pharmaceutical composition for treating and/or preventing cancer
Inventor: KURIHARA AKIRA
IPC: A61K39/395
Filed: 2016-04-28
Abstract: The purpose of the present invention is to provide the use, as a therapeutic and/or prophylactic agent for cancer, of an antibody which identifies and targets a cancer antigen protein specifically expressed on the surfaces of cancer cells. This pharmaceutical composition for treating and/or preventing cancer is characterized by including, as an active ingredient, an antibody or a fragment thereof which exhibits immunological reactivity with: a CSPG5 protein comprising any of the amino acid sequences represent by SEQ. ID NO. 8, 4, 6, 10, and 12, or an amino acid sequence exhibiting at least 80% amino acid identity with any of said amino acid sequences; or a fragment of said CSPG5 protein comprising at least 7 continuous amino acids.
Patent AU-2016261068-A1 (AU)
Title: System and methods for enhanced approval of a payment transaction
Inventor: WIESMAN MARK B
IPC: G06Q20/40
Filed: 2016-04-27
Abstract: A computer-implemented method for determining a level of confidence that a payment transaction is not fraudulent is provided. The method is implemented using an assurance exchange (AE) computer device in communication with a memory. The method includes receiving authentication data associated with a candidate payment transaction being conducted by a cardholder via a website associated with a merchant from the merchant, storing the authentication data, receiving an authorization request message for the candidate payment transaction from a payment processor, retrieving the authentication data for the candidate payment transaction based on the authorization request message, and calculating an assurance level score based on the authentication data and the authorization request message. The assurance level score represents a level of confidence that the candidate payment transaction is not fraudulent. The method also includes transmitting the authorization request message including the assurance level score to an issuer processor.
Patent AU-2016278588-A1 (AU)
Title: VEGFR-2 targeting DNA vaccine for combination therapy
Inventor: LUBENAU HEINZ
IPC: A61K39/00
Filed: 2016-06-16
Abstract: The present invention relates to an attenuated strain of Salmonella comprising at least one copy of a DNA molecule comprising an expression cassette encoding a VEGF receptor protein, for use in the treatment of cancer, wherein the treatment further comprises the administration of at least one further anti-cancer agent. The present invention further relates to a pharmaceutical composition comprising an attenuated strain of Salmonella comprising at least one copy of a DNA molecule comprising an expression cassette encoding a VEGF receptor protein, wherein the pharmaceutical composition further comprises at least one further attenuated strain of Salmonella comprising at least one copy of a further DNA molecule comprising a further expression cassette encoding a tumor antigen or a tumor stroma antigen.